Navigation Links
Patient Safety Technologies Completes $6.0 Million Equity Financing
Date:6/25/2010

NEWTOWN, Pa., June 25 /PRNewswire-FirstCall/ -- Patient Safety Technologies, Inc. (OTC Bulletin Board: PSTX) (the "Company") announced today the closing of a $6.0 million private placement financing.  The new capital will primarily be used to fund working capital and the continued growth of the Company.

Additionally, Brian E. Stewart has been appointed as President, Chief Executive Officer and Board Member of the Company.  Mr. Stewart is the co-founder of SurgiCount Medical, the Company's primary operating subsidiary, and co-inventor of the Safety-Sponge® System.  Additionally, Mr. Stewart brings over 15 years of experience financing and advising both public and private companies in addition to his experience as VP Business Development of SurgiCount Medical.  "I look forward to leading the Company at this exciting time.  With an ever increasing customer base validating the effectiveness of the Safety-Sponge® System, top-tier supply chain partners and a strengthened balance sheet, I believe we are well positioned to become the standard of care for addressing one of the most common errors in surgery, retained surgical sponges," said Mr. Stewart.

Prior to the appointment of Mr. Stewart as CEO and Director, Messrs. Chase, McFarland, Bauer and Hitchcock resigned as Directors and Steven Kane resigned as a Director, President and Chief Executive Officer.  The Board of Directors now consists of Brian Stewart, Wayne Lin, John Francis, Louis Glazer and Herbert Langsam.

In connection with the financing, certain of the stockholders who previously called for a special meeting of stockholders requesting the removal of certain directors have withdrawn such demand.  As a result, under the Company's by-laws, the demand is no longer in effect.

Additional details on the transaction will be provided in an upcoming Form 8-K filing with the Securities and Exchange Commission.

About Patient Safety Technologies, Inc. and SurgiCount Medical, Inc.

Patient Safety Technologies, Inc., through its wholly owned operating subsidiary SurgiCount Medical, Inc., provides the Safety-Sponge® System, a system designed to improve the standard of patient care and reduce healthcare costs by preventing the occurrence of surgical sponges and other foreign objects from being left inside patients after surgery.  Retained Foreign Objects (RFOs) are among one of the most common surgical errors.

For more information regarding the Safety-Sponge® System, contact SurgiCount at (877) 520-2300, or visit www.surgicountmedical.com.

Safe Harbor for Forward-Looking Statements:

Any statements that are not historical facts contained in this release are forward-looking statements. Actual results may differ materially from those projected or implied in any forward-looking statements. Such statements involve risks and uncertainties, including but not limited to: risks relating to product and customer demand; the effect of economic conditions both nationally and internationally; the ability to protect our intellectual property rights; the impact of any litigation or infringement actions brought against us; competition from other providers and products; risks in product development; our ability to raise capital to fund continuing operations; the ability to complete transactions; and other factors discussed from time to time in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made except as required by law.

Important Information

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.  The shares of convertible preferred stock have been sold pursuant to an exemption from state and federal securities laws.


'/>"/>
SOURCE Patient Safety Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Talecris Biotherapeutics CEO Accepts 2010 Ernst & Young Entrepreneur Of The Year Award on Behalf of Employees and Patients
2. Emerging Markets (BRIC - Brazil, Russia, India and China): Patient Monitors 2010 - 2014
3. Updated Results from Phase 2 Trial Demonstrate Prolonged Hematologic Relapse-Free Survival of Micromets Blinatumomab in Patients with Acute Lymphoblastic Leukemia
4. Micromets Blinatumomab Induces Durable Remissions in Patients with Relapsed Non-Hodgkins Lymphoma
5. Collaborating with Patient Advocacy Groups to Educate Physicians, Patients and Thought Leaders
6. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
7. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
8. Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
9. Over 205 Inches Lost by Chicago Area Patients at Complete Clinics Using Zerona(TM) Lipo Laser
10. FIRMAGON® Results in Fast, Long-Term Suppression of Testosterone in Prostate Cancer Patients Without Initial Testosterone Surge
11. Extension Study With FIRMAGON® (degarelix) Showed Continued Benefits for Prostate Cancer Patients Beyond One Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... Prepacked Chromatography columns are widely ... and beverage industry, water and environmental industry, ... laboratories. Acceptance of prepacked chromatography columns is ... pharma companies are increasing, which is anticipated ... Increasing research and development (R&D) activities has ...
(Date:2/28/2017)... SOUTH SAN FRANCISCO, Calif. , Feb. 27, ... company developing proprietary therapeutics for the treatment of ... drug delivery platform, today announced that the U.S. ... initial review of the ropinirole implant Investigational New ... hold the initiation of the clinical study pending ...
(Date:2/28/2017)... Feb. 27, 2017  Market Research presents an all-encompassing and ... optics market titled ,Medical Fiber Optics Market: Global Industry Analysis ... trends globally across the five key regions of ... Europe , APAC and MEA which influence ... fiber optics market over the forecast period. In this report, ...
Breaking Medicine Technology:
(Date:2/28/2017)... ... February 28, 2017 , ... ... from 4:30-5:30 p.m. at the 11th Annual RISE Nashville Summit. RISE Nashville is ... performance analytics, and engagement strategies. , The discussion will include best practices for ...
(Date:2/27/2017)... Sedona, Arizona (PRWEB) , ... February 27, 2017 ... ... Premier Center for Shamanic Healing and Spiritual Awakening, is happy to announce ... reboot for mind and body, these individual customized retreats offer the winter-weary soul ...
(Date:2/27/2017)... ... February 27, 2017 , ... This webinar ... analysis as a tool to characterize particle size distributions in the field of ... results and novel scientific findings. It describes methods of optimized and standardized sample ...
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... for hair transplantation therapy, is proud to announce a new informational post on ... therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) ...
(Date:2/26/2017)... ... 2017 , ... This is an extension of airmid’s scope ... ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite allergen) & ... standard that sets out requirements for the technical competence of testing and calibration ...
Breaking Medicine News(10 mins):